Texas House bill in Session 892.
Status: introduced. Latest action: September 17, 2025.
Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
The bill author informed the House Committee on State Affairs that, following the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization (2022), which overturned Roe v. Wade , states have regained the authority to protect women and unborn children from abortion but that in recent years, abortion-inducing drugs are being purchased online from out-of-state abortion providers and entities. As reported in the Texas Tribune , an average of 2,800 Texans receive abortion-inducing drugs each month according to #WeCount, a tracking project from the Society of Family Planning. The bill author also informed the committee that, without in-person medical care, follow-up care, or preventative testing�such as a physical exam, diagnostic ultrasound, or blood test�it is possible that serious health risks from the use of abortion-inducing
| Date | Event | Detail |
|---|---|---|
| 2025-08-20 | Introduced | Bill introduced |
| 2025-09-17 | Status | introduced |
| 2025-09-17 | Latest Action | Effective on . . . . . . . . . . . . . . . December 4, 2025 |